 |
|
Home | Vascular Access Technologies Inc. has developed the SAFECVAD(TM), an innovative device that allows physicians a safer approach to central vein access |
 |
Vascular Access Technologies Inc. has developed the SAFECVAD(TM), an innovative device that allows physicians a safer approach to central vein access
|
 |
- March 02, 2012
-
Central venous access is essential for medical treatments of many major medical conditions, including cancer, kidney failure and cardiovascular diseases. Although performed millions of times a year, it is associated with an abnormally high rate of complications, especially for the growing population of high-risk patients who are most in need of access for life-sustaining care.
Central venous access is performed over five million times a year in the United States alone, enabling central line placements that are needed for life-sustaining treatments including hemodialysis, chemotherapy, antibiotic delivery and heart implants.
For the past 50 years, the standard of care ...
- Read more at:http://www.1888pressrelease.com/vascular-access-technologies-inc-has-developed-the-safecvad-pr-378717.html
|
 |
|
 |
|
 |
